Rare individuals have been multiply exposed to HIV-1 but remain uninfected. The CD4 + T-cells
of two of these individuals, designated EU2 and EU3, are highly resistant in vitro to the …

The β-chemokines MIP-1α, MIP-1β and RANTES inhibit infection of CD4 + cells by primary,
non-syncytium-inducing (NSI) HIV-1 strains at the virus entry stage, and also block env-…

The thymus represents the major site of the production and generation of T cells expressing
αβ-type T-cell antigen receptors 1 . Age-related involution 2 may affect the ability of the …

Virologic and immunologic studies were performed on five patients presenting with primary
human immunodeficiency virus type 1 (HIV-1) infection. CD8+ cytotoxic T lymphocyte (CTL) …

In the coronavirus efficacy (COVE) phase 3 clinical trial, vaccine recipients were assessed
for neutralizing and binding antibodies as correlates of risk for COVID-19 disease and as …

Establishing a CD8 + T cell–mediated immune correlate of protection in HIV disease is crucial
to the development of vaccines designed to generate cell-mediated immunity. Historically, …

Background In the RV144 trial, the estimated efficacy of a vaccine regimen against human
immunodeficiency virus type 1 (HIV-1) was 31.2%. We performed a case–control analysis to …

Flow cytometric detection of antigen-specific CD8+ T cells has previously been limited to
MHC-class I tetramer staining or intracellular cytokine production, neither of which measure the …

A 32–nucleotide deletion (δ32) within the β–chemokine receptor 5 (CCR5) gene has been
described in subjects who remain uninfected despite extensive exposure to HIV–1. This allele …

HIV infection is associated with the progressive loss of CD4 + T cells through their destruction
or decreased production 1 , 2 . A central, yet unresolved issue of HIV disease is the …